What does Fifth Era Acquisition Corp I do?
Fifth Era Acquisition Corp I is not an operating technology or metals company. It is a Cayman Islands special purpose acquisition company, or SPAC, listed on the Nasdaq Global Market under FERA. Its purpose is to hold investor capital in trust, identify a private business, negotiate a combination, obtain approvals, and convert the resulting enterprise into a publicly traded company. The company’s final IPO prospectus originally described a broad mandate with emphasis on technology-enabled businesses, including internet, enterprise software, artificial intelligence, fintech, and blockchain.
Why is the company economically different from a normal public business?
FERA has no customers, operating revenue, products, or operating segments. Before a merger, trust interest is offset by legal, accounting, listing, administrative, and transaction expense. Conventional gross-margin or customer-growth analysis is therefore irrelevant; trust protection, closing capability, redemption obligations, and transaction costs matter instead.
| Identity item | FERA detail | Research implication |
|---|---|---|
| Legal form | Cayman Islands exempted company; incorporated May 22, 2024 | Governance, liquidation, and merger mechanics follow Cayman law plus U.S. securities rules. |
| Listing | Nasdaq: FERA; units FERAU; rights FERAR | The ordinary shares, units, and rights carry different economics. |
| Business status | Shell company with no operating revenue through Q1 2026 | Current income is trust interest, not business profit. |
| Announced target | SMT Holdings Limited, operating as Miotal | The analysis is now primarily a transaction-completion and post-merger diligence case. |
The investor page and Nasdaq listing page confirm FERA’s public identity; economically, it remains a merger vehicle until closing.
How does FERA make money before a merger?
The IPO funded a restricted trust invested in permitted Treasury-oriented instruments or cash. Interest accrues in the trust, while operating and transaction expenses are paid from outside cash, sponsor support, or permitted loans. FERA can therefore report positive GAAP income without an operating business.
What are the unit and right economics?
Each $10.00 unit contained one Class A share and one right to receive one-tenth of a share at closing. The 23.6 million public and private rights could create about 2.36 million additional shares, before adjustments and rounding. On liquidation, rights expire worthless and receive no trust distribution.
| Security or cash source | Official amount | Economic role | Primary risk |
|---|---|---|---|
| Public units | 23.0M at $10.00, March 2025 | Funded the trust and created public shares plus rights. | Shareholders may redeem rather than fund the merger. |
| Private placement units | 0.6M at $10.00, or $6.0M | Provided sponsor and underwriter capital outside the public offering. | Private securities can become worthless if FERA liquidates. |
| Public and private rights | 23.6M rights; 0.1 share per right | Potentially add about 2.36M shares at closing. | Dilution for continuing shareholders; zero value on liquidation. |
| Deferred underwriting fee | $10.95M payable at closing | A transaction-contingent cash cost equal to 4.8% of IPO gross proceeds. | The fee does not decline merely because public shares are redeemed. |
What does FERA’s latest reported quarter show?
For the quarter ended March 31, 2026, FERA reported no operating revenue, $799,742 of G&A expense, $2.091 million of trust interest, and $1.292 million of net income. Basic and diluted EPS was $0.04 for both share classes, reflecting trust income rather than Miotal’s economics.
| Metric | Q1 2026 / Mar. 31, 2026 | Prior comparison | Interpretation |
|---|---|---|---|
| Trust assets | $239.946M | $237.855M at Dec. 31, 2025 | Trust value increased $2.091M during Q1, matching reported interest. |
| Total assets | $240.526M | $238.584M at Dec. 31, 2025 | Almost the entire asset base is restricted trust capital. |
| Current liabilities | $3.764M | $3.114M at Dec. 31, 2025 | Accrued costs rose while unrestricted cash fell. |
| Net cash used in operations | $0.173M | $0.416M in Q1 2025 | Cash burn improved year over year, but the outside-trust pool remains small. |
| Redemption value | $10.43 per public share | $10.34 at Dec. 31, 2025 | Accrued trust income raised the cash election value. |
How much of the balance sheet is truly available for operations?
Unrestricted cash of $370,084 covered about 9.8% of $3.764 million in current liabilities. The trust remained intact, but outside-trust liquidity—not total assets—is the better short-term health measure. Read the Q1 2026 Form 10-Q as a liquidity and transaction-status report.
Why does the Miotal transaction change FERA’s story?
On April 7, 2026, FERA signed a combination agreement with SMT Holdings Limited, or Miotal. FERA would become a subsidiary of a new Cayman Holdco, each FERA Class A and Class B share would convert into one Holdco share, and Miotal holders would receive Holdco stock valued at $10.0 billion at $10.00 per share, subject to adjustments. The Q1 filing expected closing in the second half of 2026, subject to approvals and conditions.
What would the combined company actually own?
Miotal is described as acquiring, holding, and monetizing high-purity materials such as ultrafine copper powder, nickel wire, and rare earth metals for defense, semiconductor, energy, and healthcare uses. The announcement does not replace audited financials, stockpile valuation methods, title evidence, customer data, or cash-flow history; those disclosures are central to the registration and proxy materials.
| Deal element | Disclosed term | Why it matters |
|---|---|---|
| Exchange ratio | Each FERA Class A and Class B share converts into one Holdco share | Current FERA holders roll into the new parent rather than receiving target shares directly. |
| Miotal consideration | $10.0B at $10.00 per Holdco share | The agreed equity issuance is vastly larger than FERA’s trust and will determine ownership concentration. |
| Required approvals | FERA shareholders, Miotal shareholders, effective registration statement, Nasdaq listing, and other conditions | The agreement is not the same as a completed merger. |
| Target business | Acquisition, holding, and monetization of strategic metals | Post-close valuation will depend on inventory quality, title, liquidity, monetization timing, and costs. |
| Sponsor support | Sponsor agreed to vote for the transaction and address specified costs above $15.0M | Support improves execution certainty but also highlights sponsor incentives and control. |
Primary terms appear in the transaction 8-K, combination agreement, and official announcement.
Which turning points explain FERA’s current position?
FERA’s history is short, so each event materially changes the analytical frame. The relevant timeline is not a product-development story; it is a sequence of financing, search, governance, and transaction milestones.
-
May 22, 2024FERA was incorporated as a Cayman Islands blank-check company. This established the legal vehicle but no operating business.
-
February 27, 2025The IPO registration became effective, formalizing the $10.00 unit structure and one-tenth-share rights.
-
March 3, 2025The company closed a 23.0 million-unit IPO after full exercise of the 3.0 million-unit over-allotment, raising $230.0 million gross.
-
September 15, 2025The sponsor transferred 922,313 founder shares to CEO Mitchell Mechigian, changing the disclosed beneficial-ownership map.
-
March 20, 2026Donald Putnam joined the board after Gary Cookhorn resigned, adding finance, machine-learning, and asset-management experience.
-
April 7, 2026FERA signed the Miotal agreement, replacing target-search uncertainty with closing, valuation, disclosure, and redemption risk.
-
May 8, 2026Christopher Nelson became chief financial officer after Christopher Linn resigned without a reported disagreement, preserving transaction reporting continuity.
-
March 3, 2027Current combination deadline. Without a completed transaction or approved extension, FERA must redeem public shares and wind up.
What does the timeline say about execution quality?
Full exercise of the over-allotment maximized the trust. Miotal was announced about thirteen months after the IPO, leaving nearly eleven months before the outside date. That runway is meaningful, but the cross-border deal still requires audits, controls, registration filings, shareholder communications, and Nasdaq coordination.
What is FERA’s competitive position among acquisition vehicles?
FERA competes with other SPACs, strategic acquirers, private equity, growth capital, direct listings, and IPOs. Its sponsor network brings technology, fintech, blockchain, venture, and governance experience. The Miotal agreement shows willingness to pursue a differentiated physical-asset platform tied to advanced-industry supply chains.
Where can sponsor experience become a weakness?
Sponsor-led sourcing also creates conflicts. Management has outside obligations, founder and private securities gain value through closing, no third-party Miotal valuation was obtained, and the sponsor committed its vote. Redemption rights remain, but the process is not equivalent to an independently priced underwritten IPO.
| Alternative path | Potential advantage versus FERA | Potential disadvantage versus FERA |
|---|---|---|
| Traditional IPO | Underwriter diligence, roadshow price discovery, and a conventional operating-company prospectus | Longer preparation, market-window risk, and less certainty over timing |
| Strategic acquisition | Industrial synergies, established balance sheet, and integration resources | Target shareholders lose independent public-market exposure |
| Private equity | Concentrated governance and private restructuring flexibility | Less public liquidity and potentially more leverage |
| FERA de-SPAC | Existing listing vehicle, trust capital, negotiated valuation, and sponsor network | Redemptions, dilution, deadline pressure, and sponsor conflicts |
Who owns FERA and how is control structured?
At March 31, 2026, FERA had 23.6 million Class A shares and 7.666667 million Class B shares, or 31.266667 million ordinary shares. Class A included 23.0 million redeemable public shares and 0.6 million private placement shares. Founder shares represented about 24.5%, creating meaningful sponsor influence despite public investors funding almost all trust capital.
How concentrated is sponsor influence?
A September 2025 Schedule 13D amendment reported 7.124354 million sponsor-group shares, or 22.8%, after 922,313 founder shares moved to CEO Mitchell Mechigian. Including those individual shares, Mechigian was reported at 8.046667 million shares, or 25.7%. The figures overlap and must not be added.
| Holder or group | Shares / stake | Source period | Governance significance |
|---|---|---|---|
| Fifth Era Acquisition Sponsor I LLC | 7.124354M beneficial shares; 22.8% | Schedule 13D/A, Sept. 2025 | Sponsor agreed to vote for the Miotal transaction and controls founder economics. |
| Mitchell Mechigian | 8.046667M beneficial shares; 25.7%, including 922,313 held individually | Schedule 13D/A, Sept. 2025 | CEO combines executive responsibility with substantial voting influence. |
| Public Class A shareholders | 23.0M redeemable shares | March 31, 2026 | They provide trust capital and can redeem rather than remain in Holdco. |
| Board | Five directors after March 2026 change | Q1 2026 / May 2026 filings | Oversees the transaction, conflicts, disclosure, and closing decisions. |
The official Schedule 13D amendment and the sponsor support agreement are more useful than an ownership aggregator because they show both the shares and the transaction commitments.
Which risks could derail the Miotal combination?
FERA’s risks are mostly event-driven: filing delays, failed approvals, Nasdaq issues, high redemptions, cost escalation, uncertainty around Miotal’s assets and financials, and the SPAC deadline. The Q1 filing also stressed that the board obtained no third-party Miotal valuation.
How do redemptions and dilution interact?
Public holders may redeem for trust value rather than accept Holdco shares. High redemptions reduce closing cash and float, while rights, founder shares, and the $10.0 billion Miotal issuance expand the equity base. Continuing per-share economics therefore depend on redemptions, dilution, costs, and financing—not only the $10.43 March 2026 trust value.
| Risk | Financial line affected | Concrete indicator | Potential consequence |
|---|---|---|---|
| High redemptions | Cash delivered at closing | Public shares redeemed out of 23.0M | Less growth capital, lower float, and possible financing need. |
| Disclosure or audit delay | Transaction timetable and expenses | Registration effectiveness and proxy mailing | Higher costs and less time before March 3, 2027. |
| Asset valuation uncertainty | Post-close equity value | Independent verification, title, quality, and realizable sales data | The $10.0B negotiated value may not translate into market value. |
| Sponsor conflict | Governance and deal terms | Founder economics, voting commitment, and waivers | Incentives to close may differ from public-holder preferences. |
| Liquidation | Public share redemption and right value | No completed deal by deadline | Public shares receive trust cash; rights expire worthless. |
The 2025 Form 10-K supplies the broad SPAC risk framework; Q1 2026 adds Miotal-specific risks.
Which KPIs matter most for FERA?
A SPAC should be monitored with transaction and liquidity metrics rather than operating-company KPIs. Revenue growth is zero by design. The useful dashboard tracks trust protection, unrestricted cash, cash burn, redemption value, deadline runway, transaction progress, dilution, and the quality of target disclosure.
How should researchers calculate the core ratios?
Trust concentration equals trust assets divided by total assets: $239.946 million divided by $240.526 million, or about 99.8% at March 31, 2026. Outside-cash coverage equals unrestricted cash divided by current liabilities: $0.370 million divided by $3.764 million, or about 9.8%. Quarterly cash burn was $173,174 in Q1 2026. Potential rights dilution is rights outstanding multiplied by 0.1 share, or roughly 2.36 million shares from 23.6 million rights if the transaction closes under the stated mechanics.
Why is FERA unusual in a DCF analysis?
A stand-alone DCF is not very informative before closing: the trust resembles a cash claim and FERA has no recurring operating cash flow. Pre-close valuation should probability-weight redemption, deal completion, dilution, costs, and Holdco value. A conventional DCF requires Miotal’s audited history and assumptions for monetization, expenses, taxes, reinvestment, and working capital.
Which valuation drivers should replace a simple price-to-earnings ratio?
Asset value is not the same as distributable cash flow. A DCF needs the timing and cost of converting inventory into cash. Until those inputs are disclosed, $10.0 billion remains a negotiated exchange term, not a complete valuation conclusion.
What is the key takeaway from FERA analysis?
FERA is a cash-backed acquisition vehicle. At March 31, 2026, trust assets were $239.946 million and redemption value was $10.43 per public share, while outside cash was only $370,084 against $3.764 million of current liabilities. Miotal provides a target but adds complexity.
What should students, researchers, and investors monitor next?
- Registration and proxy materials, especially audited Miotal financials and stockpile verification.
- Pro forma ownership after Miotal issuance, FERA rollover, rights conversion, and financing.
- The public-share redemption rate out of 23.0 million redeemable shares.
- Cash delivered after redemptions, the $10.95 million deferred fee, and other costs.
- Evidence that required minimum stockpile sales and other closing conditions have been satisfied.
- Nasdaq approval, shareholder votes, and progress against the March 3, 2027 deadline.
- Changes in board, executive, sponsor, or beneficial ownership disclosed in later SEC filings.
- A credible bridge from physical inventory to free cash flow and terminal value.
The May 2026 CFO transition was disclosed without disagreement over accounting or reporting matters in an official Form 8-K. That is useful context, but the decisive evidence will be the transaction filings and the eventual closing statement.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
